RxDoctor Payments Data

Rodolfo Perez Gallardo, MD

Family Medicine · Fort Myers, FLNPI 1821166604

Payments from drug & device makers

$588,627in general payments, 2019–2025

Across 124 payments — averaging $4746.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$588K
  • Novo Nordisk$181
  • Pfizer$74
  • AstraZeneca$73
  • Johnson & Johnson$39
  • Boehringer Ingelheim$30
  • plus $191 from 12 others

What the payments were for

  • Food & beverage$589100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$588,627 in reported general payments places this provider in the 95th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida

Medicare billing

Part B allowed, 2024
$109,211
Medicare patients
578
Services billed
1,841

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban121$151,404
JardianceEmpagliflozin57$90,713
JanuviaSitagliptin Phosphate49$74,053
OzempicSemaglutide59$65,633
XareltoRivaroxaban58$54,839
MounjaroTirzepatide38$43,459
LinzessLinaclotide32$30,418
TrulicityDulaglutide19$25,474
Trelegy ElliptaFluticasone/Umeclidin/Vilanter23$24,509
MyrbetriqMirabegron16$19,700
Atorvastatin Calcium880$8,074
Rosuvastatin Calcium530$7,937
Omeprazole437$6,434
Stiolto RespimatTiotropium Br/Olodaterol Hcl12$5,826
Levothyroxine Sodium608$5,734

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$74$151,404121 claims
Boehringer IngelheimJardiance, Stiolto Respimat$30$96,53969 claims
MerckJanuvia$12$74,05349 claims
Novo NordiskOzempic$181$65,63359 claims
Johnson & JohnsonXarelto$39$54,83958 claims
AbbVieLinzess, Synthroid$588,037$36,012135 claims
GSKTrelegy Ellipta$25$24,50923 claims
Astellas Pharma US IncMyrbetriq$16$19,70016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,282 family medicine providers in Florida.

Other family medicine in Fort Myers

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →